VANGUARD GROUP INC 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Sale | 2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | VANGUARD GROUP INC | 1,475,350 3.650% | -673,703 (-31.35%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | VANGUARD GROUP INC | 2,149,053 5.330% | 2,149,053 (New Position) | Filing |